These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11151926)

  • 21. Unrecognized drug interactions with famotidine and nizatidine.
    Arch Intern Med; 1991 Apr; 151(4):810, 814, 815. PubMed ID: 1672811
    [No Abstract]   [Full Text] [Related]  

  • 22. Famotidine and long QT syndrome.
    Lee KW; Kayser SR; Hongo RH; Tseng ZH; Scheinman MM
    Am J Cardiol; 2004 May; 93(10):1325-7. PubMed ID: 15135720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of famotidine in adult patients with end-stage renal disease: assessment of dosing and mental status changes.
    Redmond AM; Pentapaty N; Weibel J; Nolan SF; Hudson JQ; Self T
    Am J Med Sci; 2005 Jul; 330(1):8-10. PubMed ID: 16020993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ; Fennerty B; Fagan TC
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Famotidine induced parkinsonism in a case of essential tremor].
    Katsumata S; Mizuno S; Shirata A; Yamane K
    Nihon Naika Gakkai Zasshi; 2002 Jan; 91(1):456-8. PubMed ID: 11925958
    [No Abstract]   [Full Text] [Related]  

  • 26. Toxic epidermal necrolysis (Lyell syndrome) following famotidine administration.
    Brunner M; Vardarman E; Goldermann R; Goerz G; Niederau D; Merk HF; Scharffetter-Kochanek K
    Br J Dermatol; 1995 Nov; 133(5):814-5. PubMed ID: 8555043
    [No Abstract]   [Full Text] [Related]  

  • 27. [Toxic cholestatic hepatitis due to phenytoin].
    de la Serna Higuera C; Gil Grande LA; Bárcena Marugán R
    Gastroenterol Hepatol; 1995 Nov; 18(9):471-3. PubMed ID: 8521225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of famotidine-induced aseptic meningitis].
    Ishihara O; Omata T
    Rinsho Shinkeigaku; 2000 Jan; 40(1):48-50. PubMed ID: 10825801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute kidney failure and acute toxic cholestatic hepatitis caused by a large amount of analgin].
    Monov A; Chernev K; Penkova S; Boshnakova Ts
    Vutr Boles; 1985; 24(1):133-6. PubMed ID: 4024603
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute cholestatic hepatitis induced by glimepiride].
    Sitruk V; Mohib S; Grando-Lemaire V; Ziol M; Trinchet JC
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1233-4. PubMed ID: 11173739
    [No Abstract]   [Full Text] [Related]  

  • 31. Ranitidine induced hepatitis.
    Lee TH; Vega KJ; El Khoury JG
    J Gastrointestin Liver Dis; 2010 Sep; 19(3):337-8. PubMed ID: 20922203
    [No Abstract]   [Full Text] [Related]  

  • 32. Famotidine and acquired long QT syndrome.
    Endo T; Katoh T; Kiuchi K; Katsuta Y; Shimizu S; Takano T
    Am J Med; 2000 Apr; 108(5):438-9. PubMed ID: 10759110
    [No Abstract]   [Full Text] [Related]  

  • 33. [Toxic hepatitis caused by ebrotidine].
    Castellote J; Porta F
    Med Clin (Barc); 1998 Nov; 111(17):676. PubMed ID: 9881355
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute cholestatic hepatitis associated with pravastatin.
    Hartleb M; Rymarczyk G; Januszewski K
    Am J Gastroenterol; 1999 May; 94(5):1388-90. PubMed ID: 10235223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cholestatic hepatitis and anemia induced by ticlopidine].
    Pascual S; Sarrión JV; Jarque I; Argüello L; Berenguer J
    Gastroenterol Hepatol; 1996 Apr; 19(4):208-9. PubMed ID: 8665360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The tolerability and safety profile of famotidine.
    Howden CW; Tytgat GN
    Clin Ther; 1996; 18(1):36-54; discussion 35. PubMed ID: 8851452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute submassive cholestatic hepatitis after treatment with carbimazole. Presentation of a new case and review of the literature].
    Moreno Sánchez D; Medina Asensio J; Colina Ruiz-Delgado F; Campos Cantero R; Crespo Rincón L; Belda Serna A
    Rev Esp Enferm Apar Dig; 1989 Sep; 76(3):273-6. PubMed ID: 2682839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Famotidine augmentation in schizophrenia: hope or hype?
    Andrade C
    J Clin Psychiatry; 2013 Sep; 74(9):e855-8. PubMed ID: 24107771
    [No Abstract]   [Full Text] [Related]  

  • 39. A case of famotidine-induced anaphylaxis.
    Kim YI; Park CK; Park DJ; Wi JO; Han ER; Koh YI
    J Investig Allergol Clin Immunol; 2010; 20(2):166-9. PubMed ID: 20461973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Famotidine in the management of schizophrenia.
    Martinez MC
    Ann Pharmacother; 1999 Jun; 33(6):742-7. PubMed ID: 10410190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.